ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Halozyme Therapeutics Incorporated

Halozyme Therapeutics Incorporated (HALO)

59.61
0.00
(0.00%)
Closed November 13 4:00PM
59.61
-0.03
(-0.05%)
After Hours: 6:00PM

Halozyme Therapeutics Incorporated Financial Summary

The current HALO market cap is 7.58B. The company's latest EPS is USD 2.2133 and P/E is 26.95.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 216.03M230.04M195.88M231.35M290.08M
Operating Income 88.28M101.04M95.54M117.24M163.2M
Net Income 81.84M85.39M76.82M93.25M137.01M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 195.99M267.59M443.31M660.12M829.25M
Operating Income -67.61M144.26M275.9M267.53M337.57M
Net Income -72.24M129.09M402.71M202.13M281.59M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.89B1.73B1.84B1.97B2.12B
Total Liabilities 1.64B1.65B1.66B1.68B1.67B
Total Equity 249.18M83.81M177.81M289.42M452.7M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 565.87M579.92M1.1B1.84B1.73B
Total Liabilities 474.11M428.88M907.48M1.67B1.65B
Total Equity 91.77M151.05M196.95M169.8M83.81M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 286.22M388.57M129.43M185.22M300.6M
Investing -88.62M-96.91M-82.68M-124.72M-292.2M
Financing -158.07M-407.99M-489k8.99M27.55M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -85.42M55.45M299.44M240.11M388.57M
Investing -5.55M78.35M-406.29M-487.01M-96.91M
Financing 153.22M-106.28M77.87M362.37M-407.99M
Market Cap 7.58B
Price to Earnings Ratio 26.95
Price to Sales Ratio 9.15
Price to Cash Ratio 64.1
Price to Book Ratio 90.54
Dividend Yield -

Share Statistics

Shares Outstanding 127.23M
Average Volume (1 week) 1.26M
Average Volume (1 Month) 1.25M
52 Week Change 60.59%
52 Week High 65.5327
52 Week Low 33.15
Spread (Intraday) 0.35 (0.58%)

Company Info

Company Name Halozyme Therapeutics Incorporated
Address 1209 orange street
wilmington, delaware 19801
Website https://www.halozyme.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock